iFrame - Press Releases GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis 7/26/2024 DOWNLOAD GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial 7/9/2024 DOWNLOAD GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASH 6/17/2024 DOWNLOAD GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary Cholangitis 6/10/2024 DOWNLOAD GENFIT to Present Latest ACLF Research at EASL Congress™ 2024 5/29/2024 DOWNLOAD
GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis 7/26/2024 DOWNLOAD
GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial 7/9/2024 DOWNLOAD
GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASH 6/17/2024 DOWNLOAD
GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary Cholangitis 6/10/2024 DOWNLOAD